Compare Recursion Pharmaceuticals Inc (RXRX) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Clear Secure Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $4.36 (market cap $2.14B), while Clear Secure Inc trades at $43.43 (market cap $4.44B). The key difference: Clear Secure Inc is far larger — about 2.1× Recursion Pharmaceuticals Inc's market cap, and Clear Secure Inc pays a 1.33% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Recursion Pharmaceuticals Inc for 23 Days and Clear Secure Inc for 19 Days on average.
| RXRX | YOU | |
|---|---|---|
Market Cap | $2.14B | $4.44B |
Volume | 30,789,535 | 1,477,828 |
Sector | Health | Technology |
52-Week High | $6.79 | $62.36 |
52-Week Low | $2.84 | $29.61 |
Typical Hold Time | 23 Days | 19 Days |
Enterprise Value | $1.66B | $3.59B |
Dividend Yield | — | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RXRX trades at $3.95, down 7.49% in the last session, reflecting ongoing volatility. The company reported a net loss of $644.76M in 2025, with a negative net income margin of -961.97%, though recent quarters have shown mixed earnings beats. Technical indicators are bullish overall, with moving averages signaling strength. Strategic partnerships, such as the extended data license with Tempus AI (Business Wire, 2026-09-21), aim to bolster its AI-driven drug discovery platform, but high cash burn remains a concern.
The outlook is cautious; while analyst consensus is 40% buy and 60% hold (MarketBeat, 2026-09-20), the stock faces significant risks from persistent losses and slow revenue growth. Upside potential hinges on pipeline success, but investors must weigh the high valuation (P/S of 37.14) against operational challenges and competitive pressures in biotech.
Clear Secure (YOU) trades at $43.08, up 1.17% on the day, with a bullish technical signal despite mixed moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $0.49 versus $0.3967 expected, and revenue growth accelerated to 27% year-over-year. Analyst consensus is a Buy with a $61.40 price target, implying significant upside. Recent news highlights strategic partnerships, including integration with CrowdStrike's Falcon platform, and the launch of corporate membership programs.
The outlook for YOU is positive, driven by robust membership growth, expanding profit margins, and strategic initiatives. Key risks include execution challenges in new enterprise offerings, competitive pressures in identity verification, and sensitivity to travel industry trends. The stock's high P/E of 29.11 and P/B of 21.5 reflect growth expectations but warrant monitoring for sustainability amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
